BRIGHT MINDS BIOSCIENCES INC (DRUG)
CA10919W4056 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to DRUG. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.8. This target is 603.8% above the current price.
DRUG was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about DRUG.
In the previous month the buy percentage consensus was at a similar level.
DRUG was analyzed by 7 analysts. More opinions would make the average more meaningful.